Payment overview · 2025
General Payments
$297.15
10 reported records · 5 companies
Healthcare provider profile · identity verified
Syed Ali, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · HARTFORD, CT · NPI 1194923128
Verified facts
What the public records show
CMS Open Payments records show Syed Ali, M.D. received $297.15 in general payments during 2025 across 10 reported records.
SEAGEN INC. accounted for 33.3% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 6 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Eliquis, Ingrezza, Paxlovid.
Neurocrine BioSciences, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported INGREZZA as an associated drug or biological on 126456 records involving 27390 distinct recipient NPIs. Public Medicare Part D data also shows 48 claims for Ingrezza by this doctor in 2024.
PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ABRYSVO as an associated drug or biological on 55380 records involving 31565 distinct recipient NPIs. Public Medicare Part D data also shows 122 claims for Abrysvo by this doctor in 2024.
PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ELIQUIS as an associated drug or biological on 87112 records involving 36032 distinct recipient NPIs. Public Medicare Part D data also shows 1262 claims for Eliquis by this doctor in 2024.
PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported PAXLOVID as an associated drug or biological on 24465 records involving 15715 distinct recipient NPIs. Public Medicare Part D data also shows 15 claims for Paxlovid by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| SEAGEN INC. | Unresolved — no canonical attribution shown | $99.00 | 33.3% | 1 | 2025 |
| Neurocrine BioSciences, Inc. | Unresolved — no canonical attribution shown | $72.33 | 24.3% | 3 | 2025 |
| PFIZER INC. | Unresolved — no canonical attribution shown | $59.88 | 20.1% | 3 | 2025 |
| UCB, Inc. | Unresolved — no canonical attribution shown | $45.13 | 15.2% | 2 | 2025 |
| Alexion Pharmaceuticals, Inc. | Unresolved — no canonical attribution shown | $20.81 | 7.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $198.15 | 9 |
| Education | $99.00 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| INGREZZA Normalized: ingrezza |
Drug | Neurocrine BioSciences, Inc. | $72.33 | 3 | 2025 |
Source payment records
|
|||||
| Briviact Normalized: briviact |
Drug | UCB, Inc. | $45.13 | 2 | 2025 |
Source payment records
|
|||||
| VYNDAQEL Normalized: vyndaqel |
Drug | PFIZER INC. | $37.80 | 2 | 2025 |
Source payment records
|
|||||
| ELIQUIS Normalized: eliquis |
Drug | PFIZER INC. | $22.08 | 1 | 2025 |
Source payment records
|
|||||
| PAXLOVID Normalized: paxlovid |
Drug | PFIZER INC. | $22.08 | 1 | 2025 |
Source payment records
|
|||||
| ULTOMIRIS Normalized: ultomiris |
Biological | Alexion Pharmaceuticals, Inc. | $20.81 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| ELIQUIS eliquis |
2025 | Eliquis | 2024 | 1262 | exact normalized | Medicare Part D |
| INGREZZA ingrezza |
2025 | Ingrezza | 2024 | 48 Beneficiary count suppressed |
exact normalized | Medicare Part D |
| PAXLOVID paxlovid |
2025 | Paxlovid | 2024 | 15 | exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Neurocrine BioSciences, Inc. Exact reporting entity; no affiliate inference |
2025 | INGREZZA open payments reported associated product |
CMS Open Payments — General Payments 126456 supporting records · 27390 recipient NPIs · example record 1242766729 |
Ingrezza · 2024 Exact normalized brand match · 1 Part D row |
48 | suppressed by CMS |
| PFIZER INC. Exact reporting entity; no affiliate inference |
2025 | ABRYSVO open payments reported associated product |
CMS Open Payments — General Payments 55380 supporting records · 31565 recipient NPIs · example record 1228794147 |
Abrysvo · 2024 Exact normalized brand match · 1 Part D row |
122 | 120 |
| PFIZER INC. Exact reporting entity; no affiliate inference |
2025 | ELIQUIS open payments reported associated product |
CMS Open Payments — General Payments 87112 supporting records · 36032 recipient NPIs · example record 1228794063 |
Eliquis · 2024 Exact normalized brand match · 1 Part D row |
1262 | 125 |
| PFIZER INC. Exact reporting entity; no affiliate inference |
2025 | PAXLOVID open payments reported associated product |
CMS Open Payments — General Payments 24465 supporting records · 15715 recipient NPIs · example record 1228794432 |
Paxlovid · 2024 Exact normalized brand match · 1 Part D row |
15 | 14 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 2346 | 334 |
| Trazodone Hcl | Trazodone Hcl | 1505 | 182 |
| Eliquis | Apixaban | 1262 | 125 |
| Amlodipine Besylate | Amlodipine Besylate | 975 | 145 |
| Gabapentin | Gabapentin | 962 | 128 |
| Levothyroxine Sodium | Levothyroxine Sodium | 953 | 121 |
| Metoprolol Succinate | Metoprolol Succinate | 850 | 109 |
| Furosemide | Furosemide | 835 | 118 |
| Sertraline Hcl | Sertraline Hcl | 734 | 87 |
| Lisinopril | Lisinopril | 729 | 84 |
| Pantoprazole Sodium | Pantoprazole Sodium | 725 | 95 |
| Tamsulosin Hcl | Tamsulosin Hcl | 710 | 88 |
| Mirtazapine | Mirtazapine | 626 | 107 |
| Metformin Hcl | Metformin Hcl | 606 | 64 |
| Divalproex Sodium | Divalproex Sodium | 528 | 51 |
| Metoprolol Tartrate | Metoprolol Tartrate | 511 | 70 |
| Quetiapine Fumarate | Quetiapine Fumarate | 486 | 53 |
| Escitalopram Oxalate | Escitalopram Oxalate | 477 | 63 |
| Potassium Chloride | Potassium Chloride | 470 | 68 |
| Losartan Potassium | Losartan Potassium | 464 | 79 |
| Donepezil Hcl | Donepezil Hcl | 454 | 58 |
| Omeprazole | Omeprazole | 401 | 100 |
| Risperidone | Risperidone | 388 | 28 |
| Carvedilol | Carvedilol | 360 | 54 |
| Duloxetine Hcl | Duloxetine Hcl | 333 | 35 |
| Montelukast Sodium | Montelukast Sodium | 325 | 28 |
| Olanzapine | Olanzapine | 303 | 32 |
| Jardiance | Empagliflozin | 295 | 37 |
| Levetiracetam | Levetiracetam | 294 | 42 |
| Baclofen | Baclofen | 287 | 31 |
| Midodrine Hcl | Midodrine Hcl | 281 | 32 |
| Clopidogrel | Clopidogrel Bisulfate | 275 | 28 |
| Clozapine | Clozapine | 272 | suppressed |
| Aripiprazole | Aripiprazole | 264 | 22 |
| Famotidine | Famotidine | 260 | 45 |
| Xarelto | Rivaroxaban | 251 | 29 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 229 | 19 |
| Memantine Hcl | Memantine Hcl | 220 | 30 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 205 | 34 |
| Finasteride | Finasteride | 201 | 29 |
| Pravastatin Sodium | Pravastatin Sodium | 199 | 21 |
| Tradjenta | Linagliptin | 199 | 18 |
| Simvastatin | Simvastatin | 194 | 28 |
| Latanoprost | Latanoprost | 181 | 42 |
| Torsemide | Torsemide | 180 | 32 |
| Myrbetriq | Mirabegron | 175 | 20 |
| Allopurinol | Allopurinol | 161 | 26 |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 150 | 37 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 148 | 16 |
| Hydralazine Hcl | Hydralazine Hcl | 147 | 24 |
| Bupropion Xl | Bupropion Hcl | 146 | 19 |
| Citalopram Hbr | Citalopram Hydrobromide | 143 | 13 |
| Januvia | Sitagliptin Phosphate | 143 | 20 |
| Spironolactone | Spironolactone | 142 | 37 |
| Prednisone | Prednisone | 138 | 43 |
| Paroxetine Hcl | Paroxetine Hcl | 126 | suppressed |
| Lamotrigine | Lamotrigine | 125 | 16 |
| Abrysvo | Rsv Vacc, Pref A And Pref B/Pf | 122 | 120 |
| Diclofenac Sodium | Diclofenac Sodium | 118 | 38 |
| Propranolol Hcl | Propranolol Hcl | 117 | 16 |
| Hydrocortisone | Hydrocortisone | 115 | 13 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 113 | 54 |
| Lactulose | Lactulose | 113 | 31 |
| Methocarbamol | Methocarbamol | 111 | 28 |
| Hydrochlorothiazide | Hydrochlorothiazide | 110 | 19 |
| Tizanidine Hcl | Tizanidine Hcl | 109 | 15 |
| Fluoxetine Hcl | Fluoxetine Hcl | 108 | 17 |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 104 | suppressed |
| Atenolol | Atenolol | 102 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 99 | 30 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 98 | 13 |
| Gemtesa | Vibegron | 96 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 93 | 20 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 92 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 91 | 11 |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 89 | 20 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 88 | suppressed |
| Oseltamivir Phosphate | Oseltamivir Phosphate | 87 | 83 |
| Warfarin Sodium | Warfarin Sodium | 87 | suppressed |
| Sucralfate | Sucralfate | 86 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 86 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 82 | 13 |
| Lovastatin | Lovastatin | 79 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 79 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 78 | 15 |
| Nuplazid | Pimavanserin Tartrate | 76 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 75 | suppressed |
| Ezetimibe | Ezetimibe | 75 | 21 |
| Timolol Maleate | Timolol Maleate | 73 | 14 |
| Haloperidol | Haloperidol | 71 | 16 |
| Metformin Hcl Er | Metformin Hcl | 68 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 66 | 12 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 65 | 16 |
| Lorazepam | Lorazepam | 65 | 30 |
| Ondansetron Hcl | Ondansetron Hcl | 65 | 36 |
| Bupropion Hcl Sr | Bupropion Hcl | 64 | 13 |
| Lurasidone Hcl | Lurasidone Hcl | 64 | suppressed |
| Methimazole | Methimazole | 64 | suppressed |
| Topiramate | Topiramate | 63 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 61 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 61 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 60 | 13 |
| Valsartan | Valsartan | 60 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 59 | 23 |
| Primidone | Primidone | 58 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 58 | 11 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 57 | 29 |
| Digoxin | Digoxin | 57 | 11 |
| Amantadine | Amantadine Hcl | 54 | suppressed |
| Meloxicam | Meloxicam | 54 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 54 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 53 | 19 |
| Divalproex Sodium Er | Divalproex Sodium | 53 | suppressed |
| Lyumjev Kwikpen U-100 | Insulin Lispro-Aabc | 52 | suppressed |
| Ramipril | Ramipril | 52 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 51 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 51 | suppressed |
| Ceftriaxone | Ceftriaxone Sodium | 50 | 28 |
| Farxiga | Dapagliflozin Propanediol | 50 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 50 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 50 | 14 |
| Sevelamer Carbonate | Sevelamer Carbonate | 50 | suppressed |
| Ingrezza | Valbenazine Tosylate | 48 | suppressed |
| Austedo | Deutetrabenazine | 47 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 45 | 11 |
| Xtampza Er | Oxycodone Myristate | 45 | suppressed |
| Entresto | Sacubitril/Valsartan | 44 | suppressed |
| Methotrexate | Methotrexate Sodium | 43 | suppressed |
| Ramelteon | Ramelteon | 43 | suppressed |
| Clonazepam | Clonazepam | 42 | 12 |
| Spiriva Handihaler | Tiotropium Bromide | 42 | suppressed |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 42 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 41 | suppressed |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 41 | 20 |
| Labetalol Hcl | Labetalol Hcl | 41 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 40 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 40 | 13 |
| Enoxaparin Sodium | Enoxaparin Sodium | 39 | 17 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 39 | suppressed |
| Brilinta | Ticagrelor | 38 | suppressed |
| Celecoxib | Celecoxib | 37 | suppressed |
| Humalog | Insulin Lispro | 37 | suppressed |
| Ozempic | Semaglutide | 35 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 35 | suppressed |
| Budesonide | Budesonide | 34 | suppressed |
| Enulose | Lactulose | 34 | 14 |
| Cefpodoxime Proxetil | Cefpodoxime Proxetil | 33 | 27 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 33 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 33 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 32 | suppressed |
| Hydroxyurea | Hydroxyurea | 32 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 32 | suppressed |
| Diltiazem 24hr Er (La) | Diltiazem Hcl | 31 | suppressed |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 31 | suppressed |
| Lubiprostone | Lubiprostone | 31 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 31 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 30 | 12 |
| Doxycycline Hyclate | Doxycycline Hyclate | 30 | 22 |
| Lansoprazole | Lansoprazole | 30 | suppressed |
| Lidocaine | Lidocaine | 30 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 30 | suppressed |
| Minocycline Hcl | Minocycline Hcl | 30 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 29 | suppressed |
| Atropine Sulfate | Atropine Sulfate | 29 | 26 |
| Janumet | Sitagliptin Phos/Metformin Hcl | 29 | suppressed |
| Janumet Xr | Sitagliptin Phos/Metformin Hcl | 29 | suppressed |
| Lithium Carbonate | Lithium Carbonate | 29 | suppressed |
| Morphine Sulfate | Morphine Sulfate | 29 | 18 |
| Calcium Acetate | Calcium Acetate | 28 | suppressed |
| Levofloxacin | Levofloxacin | 28 | 14 |
| Restasis | Cyclosporine | 28 | suppressed |
| Rexulti | Brexpiprazole | 28 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 27 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 27 | suppressed |
| Xifaxan | Rifaximin | 27 | suppressed |
| Anastrozole | Anastrozole | 26 | suppressed |
| Carbamazepine | Carbamazepine | 26 | suppressed |
| Vascepa | Icosapent Ethyl | 26 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 25 | 17 |
| Ivermectin | Ivermectin | 25 | 19 |
| Metronidazole | Metronidazole | 25 | 13 |
| Movantik | Naloxegol Oxalate | 25 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 25 | 11 |
| Acyclovir | Acyclovir | 24 | suppressed |
| Colchicine | Colchicine | 24 | suppressed |
| Ranolazine Er | Ranolazine | 24 | suppressed |
| Creon | Lipase/Protease/Amylase | 23 | suppressed |
| Dextrose 5%-0.45% Nacl | Dextrose 5 %-0.45 % Sod Chlord | 23 | 14 |
| Novolog Flexpen | Insulin Aspart | 23 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 23 | suppressed |
| Rhopressa | Netarsudil Mesylate | 23 | suppressed |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 22 | suppressed |
| Fluphenazine Hcl | Fluphenazine Hcl | 22 | suppressed |
| Insulin Lispro | Insulin Lispro | 22 | suppressed |
| Linzess | Linaclotide | 22 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 22 | suppressed |
| Olanzapine Odt | Olanzapine | 22 | suppressed |
| Sodium Chloride | 0.9 % Sodium Chloride | 22 | 20 |
| Travoprost | Travoprost | 22 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 22 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 21 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 21 | suppressed |
| Multaq | Dronedarone Hcl | 21 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 21 | suppressed |
| Yupelri | Revefenacin | 21 | suppressed |
| Balsalazide Disodium | Balsalazide Disodium | 20 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 20 | suppressed |
| Rytary | Carbidopa/Levodopa | 20 | suppressed |
| Trulicity | Dulaglutide | 20 | suppressed |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 19 | suppressed |
| Glipizide Er | Glipizide | 19 | suppressed |
| Irbesartan | Irbesartan | 19 | suppressed |
| Nystatin | Nystatin | 19 | 16 |
| Santyl | Collagenase Clostridium Hist. | 19 | 15 |
| Azithromycin | Azithromycin | 18 | 11 |
| Cephalexin | Cephalexin | 18 | 14 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 18 | 11 |
| Dapagliflozin | Dapagliflozin Propanediol | 18 | suppressed |
| Mupirocin | Mupirocin | 18 | 11 |
| Terazosin Hcl | Terazosin Hcl | 18 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 18 | 12 |
| Belsomra | Suvorexant | 17 | suppressed |
| Cefadroxil | Cefadroxil | 17 | suppressed |
| Fluvoxamine Maleate | Fluvoxamine Maleate | 17 | suppressed |
| Glipizide | Glipizide | 17 | suppressed |
| Lactated Ringers | Ringer's Solution,lactated | 17 | 11 |
| Nifedipine Er | Nifedipine | 17 | suppressed |
| Trimethoprim | Trimethoprim | 17 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 17 | suppressed |
| Vancomycin Hcl | Vancomycin Hcl | 17 | suppressed |
| Brimonidine Tartrate-Timolol | Brimonidine Tartrate/Timolol | 16 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 16 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 16 | suppressed |
| Fluconazole | Fluconazole | 16 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 16 | suppressed |
| Mexiletine Hcl | Mexiletine Hcl | 16 | suppressed |
| Perphenazine | Perphenazine | 16 | suppressed |
| Pregabalin | Pregabalin | 16 | suppressed |
| Trospium Chloride | Trospium Chloride | 16 | suppressed |
| Dorzolamide Hcl | Dorzolamide Hcl | 15 | suppressed |
| Fluticasone-Vilanterol | Fluticasone/Vilanterol | 15 | suppressed |
| Galantamine Hbr | Galantamine Hbr | 15 | suppressed |
| Ketoconazole | Ketoconazole | 15 | suppressed |
| Lidocaine Hcl | Lidocaine Hcl | 15 | 14 |
| Meclizine Hcl | Meclizine Hcl | 15 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 15 | 14 |
| Scopolamine | Scopolamine | 15 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 15 | suppressed |
| Ammonium Lactate | Ammonium Lactate | 14 | suppressed |
| Dexamethasone | Dexamethasone | 14 | suppressed |
| Dextrose In Water | Dextrose 5 % In Water | 14 | suppressed |
| Lokelma | Sodium Zirconium Cyclosilicate | 14 | suppressed |
| Milrinone In 5% Dextrose | Milrinone Lactate/D5w | 14 | suppressed |
| Prednisolone Acetate | Prednisolone Acetate | 14 | suppressed |
| Rivastigmine | Rivastigmine Tartrate | 14 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 14 | suppressed |
| Trintellix | Vortioxetine Hydrobromide | 14 | suppressed |
| Valproic Acid | Valproic Acid | 14 | suppressed |
| Amoxicillin | Amoxicillin | 13 | suppressed |
| Cholestyramine | Cholestyramine (With Sugar) | 13 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 13 | suppressed |
| Donepezil Hcl Odt | Donepezil Hcl | 13 | suppressed |
| Gemfibrozil | Gemfibrozil | 13 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 13 | suppressed |
| Mesalamine Dr | Mesalamine | 13 | suppressed |
| Metolazone | Metolazone | 13 | suppressed |
| Neupro | Rotigotine | 13 | suppressed |
| Phenobarbital | Phenobarbital | 13 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 13 | suppressed |
| Trihexyphenidyl Hcl | Trihexyphenidyl Hcl | 13 | suppressed |
| Ziprasidone Hcl | Ziprasidone Hcl | 13 | suppressed |
| Acebutolol Hcl | Acebutolol Hcl | 12 | suppressed |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 12 | 11 |
| Everolimus | Everolimus | 12 | suppressed |
| Lagevrio (Eua) | Molnupiravir | 12 | 12 |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 12 | suppressed |
| Roflumilast | Roflumilast | 12 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 11 | suppressed |
| Alprazolam | Alprazolam | 11 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 11 | suppressed |
| Calcitonin-Salmon | Calcitonin,salmon,synthetic | 11 | suppressed |
| Dextrose 5%-0.9% Nacl | Dextrose 5 % And 0.9 % Nacl | 11 | suppressed |
| Lacosamide | Lacosamide | 11 | suppressed |
| Motegrity | Prucalopride Succinate | 11 | suppressed |
| Mycophenolate Mofetil | Mycophenolate Mofetil | 11 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 11 | suppressed |
| Ondansetron Odt | Ondansetron | 11 | suppressed |
| Sodium Chloride | Sodium Chloride 0.45 % | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $297.15 · 10 records | SEAGEN INC. | Briviact, ELIQUIS, INGREZZA, PAXLOVID, ULTOMIRIS, VYNDAQEL | 4 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Eliquis play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with Neurocrine BioSciences, Inc.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error